Inventor
Gregory R. Reyes
Inventor
Palo Alto, CA, US
Overview
Patents· 27 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes22%
C07KPeptides21%
A61KPreparations for medical, dental or toiletry purposes20%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests11%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms8%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations7%
Y10TTechnical subjects covered by former us classification4%
PatentTitleYear
7,094,406'Enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof'20066,455,492'Hepatitis E virus vaccine and method'20026,379,891'Method of detecting HEV infection'20026,229,005'DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent'20016,120,988'Method of detecting hev infection'20006,107,023'DNA amplification and subtraction techniques'20005,928,861'HTLV-I and HTLV-II peptide antigens and methods'19995,885,768'Hepatitis E virus peptide antigen and antibodies'19995,871,933'HTLV-I and HTLV-II peptide antigens and methods'19995,859,230'Non-A/non-B/non-C/non-D/non-E hepatitis agents and molecular cloning thereof'19995,843,639'Hepatitis C virus epitopes'19985,843,636'Hepatitis C virus epitopes'19985,824,649'DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof'19985,814,441'HTLV-I and HTLV-II peptide antigens and methods'19985,789,559'DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent'19985,770,689'Hepatitis E virus ORF Z peptides'19985,763,572'HTLV-II peptide antigens'19985,741,490'Hepatitis E virus vaccine and method'19985,686,239'Hepatitis E virus peptides and methods'19975,614,366'HTLV-I peptide antigens and kit'19975,538,865'Hepatitis C virus epitopes'19965,443,965'Hepatitis C virus epitopes'19955,436,318'Hepatitis C virus epitopes'19955,218,099'Post-transfusion, non-A, non-B hepatitis virus polynucleotides'19935,169,753'Method and kit for detecting human retrovirus'19925,108,920'Retrovirus isolated from human lymphoma cell lines'19925,066,579'HTLV-I peptide antigen and assay'1991Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1991–1998Patents assigned to GENELABS INC (6)· patent assignee history
1991–2006Based in Palo Alto, CA, US· patent location history
1992Patents assigned to UNIV CALIFORNIA (2)· patent assignee history
1993–2006Patents assigned to US HEALTH (6)· patent assignee history
1995–2002Patents assigned to GENELABS TECH INC (20)· patent assignee history
2000Patents assigned to USA (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENELABS TECH INC | 20 | 1995–2002 |
| GENELABS INC | 6 | 1991–1998 |
| US HEALTH | 6 | 1993–2006 |
| UNIV CALIFORNIA | 2 | 1992 |
| USA | 1 | 2000 |
Locations
| Location | Patents | Span |
|---|---|---|
| Palo Alto, California, US | 27 | 1991–2006 |